Principal Securities’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.9M Sell
75,385
-4,131
-5% -$333K 0.07% 252
2026
Q1
$6.89M Buy
79,516
+10,425
+15% +$999K 0.1% 183
2025
Q4
$6.64M Buy
69,091
+5,417
+9% +$526K 0.1% 186
2025
Q3
$6.06M Sell
63,674
-1,301
-2% -$120K 0.1% 193
2025
Q2
$5.66M Buy
64,975
+5,531
+9% +$469K 0.11% 186
2025
Q1
$4.75M Buy
59,444
+130
+0.2% +$11.6K 0.11% 184
2024
Q4
$4.74M Buy
59,314
+11,658
+24% +$1.01M 0.11% 183
2024
Q3
$4.29M Buy
47,656
+2,981
+7% +$251K 0.1% 189
2024
Q2
$3.52M Sell
44,675
-8,907
-17% -$730K 0.1% 197
2024
Q1
$4.67M Buy
53,582
+9,702
+22% +$828K 0.15% 136
2023
Q4
$3.61M Buy
+43,880
New +$3.34M 0.13% 152

Other funds holding MDT

Principal Securities's MDT Position: Q2 2026 in Review

Principal Securities reduced its Medtronic (MDT) stake by 5.2% in Q2 2026, selling an estimated $333K and leaving 75,385 shares worth $5.9M. The position accounts for 0.07% of the portfolio, ranked #252.

Principal Securities first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $6.89M in Q1 2026. 2,131 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Principal Securities held 75,385 shares of Medtronic worth $5.9M as of Q2 2026.
  • Principal Securities sold 4,131 Medtronic shares in Q2 2026, an estimated $333K.
  • Medtronic made up 0.07% of Principal Securities's portfolio in Q2 2026, its #252 holding.
  • Principal Securities first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • Principal Securities's Medtronic position peaked at $6.89M in Q1 2026.
  • 2,131 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Principal Securities's 13F filing for Q2 2026, filed 4 Aug 2026.